Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
invisioner's Profile
Displaying 51-100 of 519 result(s).
CYDY CytoDyn Inc
10/20/2020 7:27:05 AM
I totally agree with and also feel (1)
CYDY CytoDyn Inc
10/20/2020 7:22:18 AM
And furthermore, if the trial was c (5)
CYDY CytoDyn Inc
10/20/2020 7:11:19 AM
I do think that but it won't be unt (1)
CYDY CytoDyn Inc
10/20/2020 7:08:19 AM
That is so weird. Why didn't Nader (3)
CYDY CytoDyn Inc
10/15/2020 10:23:53 PM
You are not alone. I also fear the
CYDY CytoDyn Inc
10/15/2020 9:45:43 PM
I think there are a lot of people o (2)
CYDY CytoDyn Inc
10/15/2020 9:42:37 PM
Of course he knows the FDA system. (3)
CYDY CytoDyn Inc
10/15/2020 8:40:49 PM
If the FDA is reviewing the data, a
CYDY CytoDyn Inc
10/15/2020 8:00:47 PM
3:40. I just watched it seven times (2)
CYDY CytoDyn Inc
10/15/2020 6:19:03 PM
This is speculative. So I hope ever (3)
CYDY CytoDyn Inc
10/15/2020 5:41:19 PM
With all due respect, Respert. It i (2)
CYDY CytoDyn Inc
10/15/2020 5:37:57 PM
I agree. If the data were not being (4)
CYDY CytoDyn Inc
10/14/2020 10:56:59 PM
I think the DSMC asking to show the (1)
CYDY CytoDyn Inc
10/14/2020 7:45:08 PM
I just got a chance to really liste (6)
CYDY CytoDyn Inc
10/14/2020 4:28:00 PM
I have started to think that is wha
CYDY CytoDyn Inc
10/13/2020 6:10:00 PM
Eli Lily. Not a good look. https:// (1)
CYDY CytoDyn Inc
10/12/2020 8:37:56 AM
Nader said on FOX that the news wou
CYDY CytoDyn Inc
10/12/2020 8:37:09 AM
The FDA does not decide whether or (1)
CYDY CytoDyn Inc
10/11/2020 10:18:15 AM
My understanding is that they are r (8)
CYDY CytoDyn Inc
10/11/2020 9:29:21 AM
Good point about FOX. That was what (2)
CYDY CytoDyn Inc
10/10/2020 9:34:11 AM
Chazzle, I remember it exactly as S
CYDY CytoDyn Inc
10/10/2020 8:48:51 AM
Hi, Sean. Where did you get this in
CYDY CytoDyn Inc
10/09/2020 8:46:52 PM
As we thought would happen, Chris C (1)
CYDY CytoDyn Inc
10/09/2020 7:40:13 PM
I mentioned cenciviroc from Takeda
CYDY CytoDyn Inc
10/09/2020 4:56:42 PM
Thank you. Yes, I am aware that the
CYDY CytoDyn Inc
10/09/2020 4:31:21 PM
Yes! That is as I thought. I think (2)
CYDY CytoDyn Inc
10/09/2020 3:26:45 PM
I think it makes out chances way be (3)
CYDY CytoDyn Inc
10/08/2020 7:09:14 PM
Not only that Sean, but there are n
CYDY CytoDyn Inc
10/08/2020 5:16:11 PM
Yes, baricinib had potentially bad/
CYDY CytoDyn Inc
10/08/2020 3:07:05 PM
I am still in, but the fact of the (3)
CYDY CytoDyn Inc
10/08/2020 2:52:20 PM
It has nothing to do with Nader. It (1)
CYDY CytoDyn Inc
10/08/2020 2:45:02 PM
The reason share price is down toda (2)
CYDY CytoDyn Inc
10/08/2020 12:44:42 PM
We are much better than this, right
CYDY CytoDyn Inc
10/08/2020 12:42:39 PM
https://www.prnewswire.com/news-re
CYDY CytoDyn Inc
10/08/2020 8:20:07 AM
That is an interesting point, but m (1)
CYDY CytoDyn Inc
10/07/2020 9:02:17 PM
If you follow the tweet link, you w (1)
CYDY CytoDyn Inc
10/07/2020 8:06:34 PM
Trump seems to be okay, but other m (1)
CYDY CytoDyn Inc
10/07/2020 4:44:57 PM
Nader seemed confident. And he look (1)
CYDY CytoDyn Inc
10/07/2020 2:35:35 PM
So you are thinking next Friday for
CYDY CytoDyn Inc
10/07/2020 1:11:25 PM
Same here. I bought for Covid, but
CYDY CytoDyn Inc
10/07/2020 11:34:40 AM
One thing I didn't know is that unt
CYDY CytoDyn Inc
10/07/2020 11:08:31 AM
Thank you. That is very helpful!
CYDY CytoDyn Inc
10/07/2020 9:27:08 AM
I think people confuse Lilly and Re (1)
CYDY CytoDyn Inc
10/07/2020 9:24:07 AM
Question. We began enrolling CD12 o
CYDY CytoDyn Inc
10/06/2020 10:01:31 AM
I am a lay person and I concur.
CYDY CytoDyn Inc
10/05/2020 7:22:07 PM
Did I ever said it was a mono-thera (1)
CYDY CytoDyn Inc
10/05/2020 6:23:18 PM
He's in steroid mania. (2)
CYDY CytoDyn Inc
10/05/2020 6:21:42 PM
Fact is, an immunomodulator like le (3)
CYDY CytoDyn Inc
10/04/2020 9:59:25 PM
It's truly hard to say what is goin
CYDY CytoDyn Inc
10/04/2020 8:16:43 PM
Yes, I saw. It looks like he is rec
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • Discover the Luxurious Quilici Community in Reno, Nevada!
  • Check Point Software Tops TIME’s Best Companies of 2025 List
  • Navigating the Shifting Landscape of Active vs. Passive Investing
  • Bryan H. Shepard's Journey: Eagles, Nature, and Empowerment
  • SERES Power Unveils Innovative Range-Extender Technology
  • Chipotle's Exciting Expansion Into Asia Via SPC Partnership
  • Reflecting on Resilience: Insights from Art Ally on 9/11
  • Steven J. Jerina Appointed Vice President at Central Florida Foundation
  • KBR, Inc. Shareholder Rights Investigation: What Investors Need to Know
  • Lyno AI: Transforming Investment Through AI-Driven Trading
  • Satlink and Rivada Join Forces for Cutting-Edge Connectivity Solutions
  • Snap Inc. Investors Must Act Before October Deadline for Class Action
  • Investors Affected by Fly-E Group, Inc. Lawsuit Alerted
  • Bitcoin's Ascent: An Insight into Market Trends and Tokens
  • Understanding the Trends in Automatic Data Processing Shares
  • Analysis of National Fuel Gas's Short Interest Trends
  • Understanding Annaly Capital's Growing Short Interest Dynamics
  • Transforming Leadership: Mike Walsh Joins DKBinnovative as CEO
  • Understanding the Impact of Geopolitical Tensions on ETFs
  • Increasing Blood Donations Key to Helping Sickle Cell Patients
  • Securing $340M Refinancing for 50 & 70 Columbus Project
  • Silverts Strengthens Adaptive Fashion with Strategic Acquisition
  • Opportunity Knocks: Victoria Tower Office Sale Unveiled
  • Lord Cameron Highlights Rare Disease Innovation at Morgan Stanley
  • Seguritech Celebrates 30 Years of Innovation in Security Tech
  • DePauw University Demonstrates Significant Local Economic Influence
  • FG Communities Strengthens Presence with Recent Acquisition
  • Investigation of Quanex Building Products: Key Insights and Updates
  • Investigation Launched for AVITA Medical Investors Amid Concerns
  • Pomerantz Firm Looks Into Geely Automobile Investor Concerns
  • Spectrum Pharmaceuticals Faces Legal Challenges - SPPI Update
  • Celebrating a Century of Community at John C. Campbell Folk School
  • AstraZeneca's Koselugo Approved for Younger Pediatric Patients
  • BioXcel Therapeutics Enhances Agitation Management with BXCL501
  • Breakthrough in Cancer Treatment: PMV Pharmaceuticals Updates
  • Oracle's Record Backlog and AI Growth Propel Stock Surge
  • Avidity Biosciences Achieves Promising Milestones in DMD Trials
  • Thriving Future for Trans-1,2-Dichloroethylene Market Growth
  • CIRO Schedules Hearing for Abid Hossain: Key Details Explained
  • Gartner Inc. Insights: Analyzing Current Stock Performance
  • Understanding Current Trends in Options Trading for Exxon Mobil
  • Landsbankinn hf. Concludes Successful Covered Bond Auction
  • Understanding the Current Trends in META's Options Market
  • Insights Into Circle Internet Group's Recent Trading Trends
  • Muinzer Welcomes New Director of Asset Management for Expansion
  • Biocon Expands Horizons with New U.S. Manufacturing Facility
  • VIVA Foundation to Present Breakthrough Vascular Research in 2025
  • Acadia Healthcare Faces Challenges with Medicaid Payment Cuts
  • Experience The Witcher Through Exclusive Eyewear Designs
  • NYBRA Plastic Surgery Partners with ARSA for Enhanced Care
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site